Latvia vs Western Pacific (WHO region): Polio vaccine: inactivated second or third-dose polio vaccine (IPVc)
Latvia
99.0%
in 2025
Western Pacific (WHO region)
84.0%
in 2025
Latvia rank
1st
Western Pacific (WHO region) rank
4th
Polio vaccine: inactivated second or third-dose polio vaccine (IPVc) over time
- Latvia
- Western Pacific (WHO region)
How they compare
Latvia currently reports 99.0% against 84.0% in Western Pacific (WHO region), a difference of 15.0%.
That makes Latvia's figure about 1.2 times Western Pacific (WHO region)'s.
Across all 5 years both countries report, Latvia has been ahead every year.
Latvia ranks 1st and Western Pacific (WHO region) ranks 4th of 194 countries.
Latvia has averaged higher in every one of the 1 decades both report.
Frequently asked questions
- Which has higher polio vaccine: inactivated second or third-dose polio vaccine (ipvc), Latvia or Western Pacific (WHO region)?
- Latvia, at 99.0% against 84.0% in Western Pacific (WHO region) as of 2025.
- What is the difference in polio vaccine: inactivated second or third-dose polio vaccine (ipvc) between Latvia and Western Pacific (WHO region)?
- 15.0%, with Latvia ahead.
- How many years of comparable data are there for Latvia and Western Pacific (WHO region)?
- 5 years are reported by both, from 2021 to 2025.
- How do Latvia and Western Pacific (WHO region) rank globally for polio vaccine: inactivated second or third-dose polio vaccine (ipvc)?
- Latvia ranks 1st and Western Pacific (WHO region) ranks 4th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Polio vaccine: inactivated second or third-dose polio vaccine (IPVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.